Atorvastatin Calcium
Product Images NDC 53217-209

5 FDA label images from Aidarex Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 53217-209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Atorvastatin Calcium 1)

Chemical Structure (Atorvastatin Calcium 1)
Chemical structure of Atorvastatin Calcium, showing the molecular arrangement including aromatic rings, hydroxyl groups, and calcium ion coordination with associated water molecules.*
FDA Label Image

Figure 1 (Atorvastatin Calcium 2)

Figure 1 (Atorvastatin Calcium 2)
A graph showing cumulative incidence (%) over a period of 3.5 years comparing Atorvastatin and Placebo. The solid line represents Atorvastatin and the dashed line represents Placebo, with Atorvastatin showing a lower cumulative incidence throughout the time period.*
FDA Label Image

Figure 2 (Atorvastatin Calcium 3)

Figure 2 (Atorvastatin Calcium 3)
A line graph comparing cumulative hazard percentages over time in years for Atorvastatin versus placebo. The x-axis shows time to first primary endpoint over four years, and the y-axis shows cumulative hazard percentage. Two lines represent placebo (dashed) and Atorvastatin (solid), with Atorvastatin showing lower cumulative hazard over time. A hazard ratio (HR) of 0.63 with confidence interval and p-value is indicated on the graph.*
FDA Label Image

Figure 3 (Atorvastatin Calcium 4)

Figure 3 (Atorvastatin Calcium 4)
A Kaplan-Meier curve chart depicting the time to first major cardiovascular endpoint over a 5-year period for Atorvastatin 10 mg and 80 mg doses. The x-axis represents time in years, and the y-axis shows the percentage of subjects experiencing the event. The chart compares event rates between the two dosages, indicating hazard ratio (HR) 0.78 with confidence interval (0.69-0.89) and p-value 0.0002.*
FDA Label Image

Image Description (Atorvastatin Calcium 5)

Image Description (Atorvastatin Calcium 5)
Atorvastatin Calcium 20mg film-coated tablets, 30 count. The label shows the active ingredient Atorvastatin Calcium equivalent to 20mg, generic for Lipitor. It includes the NDC 53217-0209-30 and is packed by Aidarex Pharmaceuticals LLC. Additional label elements include dispensing cautions, dosing instruction blanks, and reference numbers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.